Literature DB >> 15196250

Iron down-regulates macrophage anti-tumour activity by blocking nitric oxide production.

L Harhaji1, O Vuckovic, D Miljkovic, S Stosic-Grujicic, V Trajkovic.   

Abstract

Although the inhibitory effect of iron on macrophage production of tumoricidal free radical nitric oxide (NO) has been reported, its possible influence on macrophage anti-tumour activity has not been established. In the present study, FeSO4 markedly reduced IFN-gamma + LPS-induced NO synthesis in mouse and rat macrophages. The effect of iron coincided with the loss of macrophage cytotoxic activity against NO-sensitive C6 rat astrocytoma and L929 mouse fibrosarcoma cell lines, as measured by MTT assay for cellular respiration and the crystal violet test for cell viability. Tumour cell survival did not improve further in the presence of FeSO4 if macrophage NO release and cytotoxicity were already blocked by aminoguanidine. In accordance with the results obtained with exogenous iron, cell membrane permeable iron chelator o-phenanthroline enhanced both macrophage NO release and anti-tumour activity. Iron also down-regulated NO production and increased the viability of L929 fibrosarcoma cells stimulated with IFN-gamma + LPS in the absence of macrophages. However, neither NO release nor cell viability was affected by iron addition to cultures of the C6 astrocytoma cell line. Iron was unable to prevent L929 and C6 cell death induced by the NO releasing chemicals SNP and SIN-1, indicating that iron-mediated inhibition of NO synthesis, rather than interference with its cytotoxic action, was responsible for the protection of tumour cells. Collectively, these results indicate that iron might protect tumour cells by reducing both macrophage and tumour cell-derived NO release.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196250      PMCID: PMC1809097          DOI: 10.1111/j.1365-2249.2004.02515.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Iron overload impairs pro-inflammatory cytokine responses by Kupffer cells.

Authors:  J K Olynyk; S L Clarke
Journal:  J Gastroenterol Hepatol       Date:  2001-04       Impact factor: 4.029

2.  Comparison of in vitro cell cytotoxic assays for tumor necrosis factor.

Authors:  D A Flick; G E Gifford
Journal:  J Immunol Methods       Date:  1984-03-30       Impact factor: 2.303

3.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

4.  Amphotericin B potentiates the activation of inducible nitric oxide synthase and causes nitric oxide-dependent mitochondrial dysfunction in cytokine-treated rodent astrocytes.

Authors:  V Trajkovic; M Markovic; T Samardzic; D J Miljkovic; D Popadic; M Mostarica Stojkovic
Journal:  Glia       Date:  2001-09       Impact factor: 7.452

5.  Nitric oxide induces the apoptosis of human BCR-ABL-positive myeloid leukemia cells: evidence for the chelation of intracellular iron.

Authors:  H Ferry-Dumazet; M Mamani-Matsuda; M Dupouy; F Belloc; D Thiolat; G Marit; M Arock; J Reiffers; M D Mossalayi
Journal:  Leukemia       Date:  2002-04       Impact factor: 11.528

Review 6.  The role of iron in cell cycle progression and the proliferation of neoplastic cells.

Authors:  Nghia T V Le; Des R Richardson
Journal:  Biochim Biophys Acta       Date:  2002-10-02

7.  Necrotic tumor cells oppositely affect nitric oxide production in tumor cell lines and macrophages.

Authors:  Djordje Miljkovic; Milos Markovic; Natalija Bogdanovic; Marija Mostarica Stojkovic; Vladimir Trajkovic
Journal:  Cell Immunol       Date:  2002-01       Impact factor: 4.868

8.  Body iron stores and the risk of cancer.

Authors:  R G Stevens; D Y Jones; M S Micozzi; P R Taylor
Journal:  N Engl J Med       Date:  1988-10-20       Impact factor: 91.245

Review 9.  Iron chelators as therapeutic agents for the treatment of cancer.

Authors:  D R Richardson
Journal:  Crit Rev Oncol Hematol       Date:  2002-06       Impact factor: 6.312

10.  Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.

Authors:  M Tsujimoto; Y K Yip; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

View more
  3 in total

1.  Biocorrosion properties and blood and cell compatibility of pure iron as a biodegradable biomaterial.

Authors:  Erlin Zhang; Haiyan Chen; Feng Shen
Journal:  J Mater Sci Mater Med       Date:  2010-04-16       Impact factor: 3.896

Review 2.  Ironing Out the Details: How Iron Orchestrates Macrophage Polarization.

Authors:  Yaoyao Xia; Yikun Li; Xiaoyan Wu; Qingzhuo Zhang; Siyuan Chen; Xianyong Ma; Miao Yu
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

3.  Risk of cancer in patients with iron deficiency anemia: a nationwide population-based study.

Authors:  Ning Hung; Cheng-Che Shen; Yu-Wen Hu; Li-Yu Hu; Chiu-Mei Yeh; Chung-Jen Teng; Ai-Seon Kuan; San-Chi Chen; Tzeng-Ji Chen; Chia-Jen Liu
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.